BrosMed Medical Earns MDSAP Certification
Release time:
2023-06-21
Dongguan-June 21, 2023-Today BrosMed announced that it has earned the Medical Device Single Audit Program (MDSAP) certification, indicating that the single regulatory audit to BrosMed satisfies the requirements of multiple regulatory jurisdictions participating in the program.
Dongguan-June 21, 2023-Today BrosMed announced that it has earned the Medical Device Single Audit Program (MDSAP) certification, indicating that the single regulatory audit to BrosMed satisfies the requirements of multiple regulatory jurisdictions participating in the program.
The MDSAP is a unique program that brings the internationally leading regulatory agencies together to perform a single regulatory audit of a medical device manufacturer´s quality management system to satisfy the requirements of multiple regulatory jurisdictions, including the Therapeutic Goods Administration of Australia, Brazil’s Agência Nacional de Vigilância Sanitária, Health Canada, Japan’s Ministry of Health, Labour and Welfare and Japanese Pharmaceuticals and Medical Devices Agency, and the U.S. Food and Drug Administration. This certification confirms BrosMed’s compliance with the high standards and regulatory requirements of most leading countries in the world.
“This certification is a key achievement for us on the road to global commercialization. It is a critical step forward in offering our intravascular interventional solutions to additional markets and reinforces our commitment to quality and safety,” said Winnie Huang, BrosMed Quality Director.
At present, BrosMed has more than 20 product series sold to over 80 countries and regions. BrosMed will continue to reinforce our commitment to high-standard quality and safety and provide more innovative products for patients around the globe.
Join with Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announced CE MDR Approval of New Generation Conger™ Plus Hydrophilic Guidewires
Designed for superior crossability and maneuverability in peripheral interventions, Conger Plus now offers 116 models with expanded sizes (OD 0.018'' to 0.038'') and lengths (up to 300cm).
2025-04-28
BrosMed to Showcase Innovative Solutions for CHIP PCI at EuroPCR 2025
Date: May 20-23, 2025 Venue: Palais des Congrès de Paris, Paris, France Booth No.: M20
2025-04-15
"Experience TCTAP 2025: Join Us with BrosMed!"
Save the Date April 23–26, 2025 and visit us at Booth #D41 to explore more highlights!
2025-04-08
Webinar Invitation | Innovations and Novel Strategies in CHIP PCI
Mark your calendar: Wednesday, March 26 🕒 18:00-19:30 (Beijing Time) | 11:00-12:30 (CET)
2025-03-19
On February 10, BrosMed and Cordis signed an agreement for the exclusive distribution of VaSecure™, BrosMed’s next-generation drug-coated peripheral balloon catheter in the China market.
2025-02-12